Catalent Inc

Common Name
Catalent
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
17,000
Ticker
CTLT
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in ...

Disclosures of Catalent

Explore Catalent's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Catalent's official channels and fully traceable to its official company sources.

The table below lists all of Catalent's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Financial & Extra-Financial Disclosure2024
Webpage captured from company’s website2023
Financial & Extra-Financial Disclosure2023
Corporate Responsibility Report (CRR)2023
10-K2023
ISAE Assurance Statement2023
ISAE Assurance Statement2023
10-K2022
Corporate Responsibility Report (CRR)2022
Verification report2022
Verification report2022
10-K2021
Corporate Responsibility Report (CRR)2021
10-K2020
CSR Report2020
10-K2019
CSR Report2019
10-K2018
10-K2017
10-K2016
10-K2015
10-K2014
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?